• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.79% Nasdaq Down 0.52%

    Alkermes plc (ALKS)

    -NasdaqGS
    70.19 Up 0.17(0.24%) 3:36PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:70.02
    Open:69.61
    Bid:70.23 x 100
    Ask:70.32 x 300
    1y Target Est:70.40
    Beta:1.21
    Next Earnings Date:N/A
    Day's Range:69.19 - 71.11
    52wk Range:38.49 - 75.17
    Volume:508,873
    Avg Vol (3m):1,002,910
    Market Cap:10.43B
    P/E (ttm):N/A
    EPS (ttm):-0.25
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ALKSUp 0.24%10.43B
    ABTDown 0.76%74.89B
    LLYDown 0.66%88.90B
    GSKDown 0.07%104.84B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):16.02
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.43
    Quarterly EPS Est (Sep-15) :-0.28
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):-4.65

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alkermes Public Limited Company, an integrated biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in various therapeutic areas. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback